Parkinson's Disease Therapeutics: Emphasis on Nanotechnological Advances

Presenting the latest information on the second most common neurodegenerative disorder in the elderly. Despite remarkable progress in various PD therapeutics, such as microRNAs and brain drug delivery systems, a few limitations impede their success. This book sheds light on the pros and cons of recently developed novel therapeutics.

Very few books have highlighted the protective efficacy of natural products, antioxidants, and biomaterial design for other diseases.

Highlights

Emphasizes novel therapeutics for Parkinson's disease, including nanotechnology, natural products and antioxidants

Discusses the pros and cons of recently developed therapy options for Parkinson's

Focuses on the efficacy of nanotechnology in overcoming the blood-brain barrier and biomaterial design